Microneedling and Metal Allergy: Questions About the Needle Material

The short answer if you have a metal allergy

If costume-jewelry earrings, metal watch bands, or belt buckles leave you with an itchy, blistering, or weeping rash, you likely have a contact allergy to nickel—the most common contact allergen in North American patch-test series. When a clinician recommends microneedling for acne scars or texture, the practical question is not abstract metallurgy. It is whether those metal needles will trigger a reaction, whether a titanium- or gold-coated cartridge is actually safer, and what to verify before you consent.

Most cosmetic microneedling needles are made of surgical stainless steel. That phrase is not one uniform material. In the grades used most often in medical devices (AISI 304 and 316), the alloy contains roughly 8% to 14% nickel by weight. The U.S. Food and Drug Administration’s microneedling devices page states that the procedure may not be suitable for people who “are allergic to stainless steel or to topical or local anesthetics or have a history of contact dermatitis to these products.” That suitability list is not a product-specific contraindication copied from every device’s professional labeling, and it is not a verdict that every metal-allergic patient will react.

Human evidence that the needles themselves caused allergic contact dermatitis is thin but real: one 2016 peer-reviewed case after a titanium-coated stainless-steel dermaroller, with a later positive nickel patch test, and two 2025–2026 case reports of gold-associated reactions after fractional radiofrequency (RF) microneedling. Bench data show the chemical risk is device-specific, not universal. In a May 2026 Dermatologic Surgery study, three of five anonymized cosmetic microneedle brands released detectable nickel on dimethylglyoxime (DMG) spot testing and two did not. Independent 2022 testing of one FDA-cleared pen cartridge—SkinPen Precision—was repeatedly DMG-negative, with a U.S. nickel coin as a working positive control. A negative spot test still cannot prove a needle is nickel-free: against the EN 1811 reference method, DMG sensitivity is only 59.3%.

Vendor pages often market titanium as hypoallergenic. Those claims are not backed by allergy outcome data, and the only published nickel case involved a titanium-coated stainless-steel device. Gold coatings are common—at least four of five brands in the 2026 screen used them—and gold is itself a documented contact allergen. There are no professional-society guidelines for prescreening metal allergy before microneedling, and no prospective study of how often nickel- or gold-allergic patients actually react.

What is actually in a microneedling needle

Clinic language often stops at “surgical stainless steel.” In metallurgy, that label covers a family of iron-chromium alloys whose nickel content varies by grade. A table adapted by Margulies and colleagues (2022) from Boyd and Hylwa’s surgical-instrument work makes the spread concrete: austenitic grades 304 and 316 carry substantial nickel, while several 400-series grades contain little or none.

The table is a composition reference, not a catalog of which rollers and pens are on the market. SkinPen Precision’s 510(k) summary (K202243) describes 14 solid “medical grade stainless steel” needles in a sterile, single-use cartridge with protrusion settings of 0–2.5 mm. It does not name the AISI grade or a nickel percentage. Other cleared pens and over-the-counter rollers may differ. Boyd and Hylwa’s operating-room screen is the reminder that bulk nickel is a poor predictor of release: only one of 128 surgical instruments they tested with DMG released detectable nickel, even though stainless instruments commonly contain nickel-bearing grades.

Coatings add a second layer of confusion. Some devices are sold with titanium-coated tips; at least four of the five brands in the 2026 Rigali screen coat needles with gold. Those coatings sit on a metal substrate. They are not the same as a solid titanium or solid gold needle, and they are not a tested hypoallergenic claim. Scanning electron microscopy in the Rigali study found cracks and fissures after use on needles from all five brands. Structural damage did not correlate with nickel positivity, so a cracked coating is not a simple on/off switch for elution. The only published nickel microneedling case used a dermaroller marketed with titanium-coated stainless-steel tips.

K202243’s labeled uses are also narrower than clinic marketing. The system is cleared to improve the appearance of facial acne scars in adults 22 and older of all Fitzpatrick skin types, and neck wrinkles in Fitzpatrick types II–IV. The cartridge is not to be resterilized or reused. How clinics handle single-use cartridges is a separate patient question, covered in Microneedling Cartridges: What Patients Can Ask About Reuse and Sterility.

What FDA clearance does and does not cover

In the United States, aesthetic microneedling devices are Class II devices under 21 CFR 878.4430, product code QAI. The regulation’s identification is a device “using one or more needles to mechanically puncture and injure skin tissue for aesthetic use.” It is not limited to motorized pens. The classification excludes devices intended for transdermal delivery of topical products such as cosmetics, drugs, or biologics.

Special controls that matter for a metal-allergy decision include:

• Needle characteristics must be identified, including length, geometry, maximum penetration depth, and puncture rate.

• Patient-contacting components must be demonstrated to be biocompatible. That review requirement is not a guarantee of zero nickel release in an already-sensitized patient.

• Patient-contacting components must have sterility data; reusable parts need validated cleaning and disinfection instructions.

• Electrical components, when present, must have electrical safety and electromagnetic compatibility data. That requirement is about electrical performance, not allergy.

FDA has authorized a limited number of microneedling devices to improve the appearance of facial acne scars, facial wrinkles, and abdominal scars in patients aged 22 and older, with uses limited to specified body areas that differ by device. No microneedling medical device is authorized for over-the-counter sale. FDA has also stated that these devices are not authorized for delivery of cosmetics, topical medications, vitamin solutions, drugs, or blood products such as platelet-rich plasma (PRP). Putting unreviewed liquids into open channels is a separate sensitization problem from needle metal, and it is the subject of Is This Microneedling Device Cleared to Deliver PRP?.

Home-use rollers sit outside this review when they do not penetrate living skin and claim only exfoliation or a smoother appearance. FDA’s consumer update describes a dermal roller with short, blunt needles that only claims to remove dead skin as an example of a product that would generally not be a medical device. If a tool was never reviewed as a QAI device, there is no public 510(k) or De Novo record of needle characteristics or biocompatibility for that product.

The published reactions: what they looked like

Documented, patch-test–linked metal reactions after cosmetic microneedling remain case reports, not incidence studies. That scarcity does not prove reactions are rare. It means the literature can establish plausibility and timing, not how often a nickel-allergic patient flares.

Yadav and Dogra reported the nickel case in Aesthetic Surgery Journal in 2016: a young adult woman treated for post-acne scarring with a Dermaroller device (Derma India) that had titanium-coated stainless-steel tips. About six days later she developed an itchy cutaneous eruption in the treated facial areas. Later patch testing was positive for nickel. Margulies and colleagues, and the 2021 Gowda systematic review, both flag a hard limit: the local anesthetics and antiseptics used in that case were never allergy tested. Topical lidocaine, tetracaine, benzocaine, and preservatives are recognized causes of procedural contact dermatitis. Without testing those products, the eruption cannot be attributed to the needle metal alone.

Gowda and colleagues reviewed 51 articles covering 1,029 patients across roller, stamp, pen, and fractional RF devices. They attributed the Yadav reaction to nickel contact dermatitis from roller devices that may contain nickel and recommended a trial procedure in a non-visible body area before treating exposed sites, to assess hypersensitivity risk. They also documented a different pathway: delayed-type granulomatous hypersensitivity with systemic symptoms after microneedling, with vitamin C serum pretreatment implicated in two of three such cases. A post-procedure rash can come from what was applied to the channels, not only from the metal.

Gold has a thinner, newer case literature. In November 2025, Seatamanoch and Ruxrungtham published a Contact Dermatitis report of gold allergy associated with persistent reactions after fractional RF microneedling. In May 2026, Berná-Rico and colleagues reported gold-induced hypersensitivity after the same class of procedure. Accessible indexes confirm the titles, journals, and topic association; device names and patch-test details were not available in public abstracts at research time, so those details are not inferred here. What can be said is that gold-coated needles are common in at least one five-brand laboratory screen, gold is a documented contact allergen, and two independent case reports now link gold allergy to fractional RF microneedling. Readers comparing mechanical needling with RF can start with Microneedling vs RF Microneedling: What Each Actually Does to Your Skin.

Do the needles actually release nickel? What the bench tests show

Nickel in an alloy is not the same as nickel ions available to skin. Release depends on the surface, the test method, and the conditions of use. The 2026 Rigali study is the first published brand-level DMG screen of cosmetic microneedles. Investigators tested used cartridges from five commercial brands, anonymized as Devices A through E.

• Three brands released nickel on DMG testing (Devices A, B, and E). Two did not (Devices C and D).

• Scanning electron microscopy showed cracks and fissures after use on needles from all five brands.

• Structural damage did not correlate with a positive DMG result. The paper does not grade which brands had “severe” versus “minor” wear, so that comparison is not available.

• At least four of the five companies (Devices A, B, C, and E) coat their needles with gold.

• The brands are anonymized. The study cannot be used to clear or implicate SkinPen Precision or any other named product.

The authors concluded that nickel, and possibly gold ion release, from microneedling could elicit allergic contact dermatitis in sensitized people, and they called for a prospective study of dermatitis and healing times after microneedling in patients with nickel or gold allergies versus those without. They did not report quantitative elution rates in µg/cm²/week. DMG is a qualitative spot test. A positive result supports detectable nickel release under the test conditions; it is not a laboratory measurement that a brand exceeded 0.5 µg/cm²/week.

Margulies and colleagues tested SkinPen Precision tips with two commercial DMG kits (Nickel Alert and Chemo Nickel Test), twice each, on new and used needles. All those tests were negative. A U.S. minted nickel used as a positive control reacted, so the reagent was active. The authors noted the result could be a true negative or nickel below what DMG can detect. That is the correct reading of a field screen, not a certificate that the cartridge is nickel-free.

Two older stainless-steel studies cut in the same direction. Boyd and Hylwa found nickel release from only one of 128 surgical instruments on DMG testing; 19 of 43 other operating-room items released nickel, showing that the problem in a clinical environment is not confined to cutting instruments. Ingber and colleagues found that AISI 316L ear-piercing posts released nickel below 0.05 µg/cm²/week and did not elicit dermatitis in nickel-allergic subjects. That 0.05 figure is the measured release in that study, not the current European Union legal limit for piercing posts or prolonged-contact articles.

How common are nickel and gold allergy, and why it matters here

Nickel allergy is common enough that a screening question is reasonable even without a microneedling guideline. It is not common enough, on present evidence, to treat every jewelry reaction as a predicted needle failure.

Warshaw and colleagues analyzed North American Contact Dermatitis Group data on 44,097 patch-tested patients from 1994 to 2014. Average nickel sensitivity was 17.5%, rising from 14.3% in 1994–1996 to 20.1% in 2013–2014. Nickel-sensitive patients were more often female, younger, and atopic; jewelry was the most common exposure, and sensitivity increased with the number of piercings. Those figures describe people referred for patch testing, not a general microneedling clinic.

In unselected populations the numbers are still high. Alinaghi and colleagues’ meta-analysis of 28 general-population studies found pooled contact-allergy prevalence of 20.1%, with nickel the leading allergen. Zhu and colleagues, summarizing those data in CMAJ (2022), cited about 11.4% nickel positivity. Their clinical note also restates the mechanism that matters for this procedure: nickel allergic contact dermatitis is a type IV (delayed) reaction, and prolonged contact plus sweat and friction can macerate skin and release nickel into it. Standard management is source removal and clinician-directed anti-inflammatory treatment—which is why this article does not give a home steroid protocol.

Gold is a different epidemiologic problem. Jensen and colleagues’ 2024 systematic review estimated pooled gold contact-allergy prevalence of 14.1% (95% CI 9.5–19.4%) among dermatitis patients, with very high heterogeneity (I² 98.3%). DermNet NZ notes that gold sodium thiosulfate patch reactions can appear up to three weeks after patch removal and can persist for months, and that a positive gold patch test explains the presenting rash in only about 10% to 15% of cases. High patch-test positivity is therefore not the same as high clinical risk from a gold-coated needle. It is a reason to disclose gold jewelry reactions, not a reason to treat every positive gold patch test as a predicted RF-microneedling disaster.

Questions to ask before you book

Margulies and colleagues found no guidelines for prescreening nickel allergy before microneedling. FDA’s device page and Cleveland Clinic’s consumer overview both put contact dermatitis or stainless-steel allergy on the list of issues to raise with a provider; neither document is a professional-society screening protocol. The questions below are decision tools from that evidence, not a treatment plan.

1. Disclose metal and jewelry reactions in plain language. Say if costume jewelry, belt buckles, watch bands, denim rivets, dental metal, or orthopedic hardware have caused rashes. Do not assume a cosmetic intake form will ask.

2. Name the device and its clearance. Ask the make and model, and whether it is FDA-cleared under product code QAI. Public De Novo and 510(k) summaries exist for legally marketed devices. Unbranded imported pens have no such record.

3. Ask what the cartridge is made of, and whether it is coated. “Surgical stainless steel,” titanium-coated, and gold-coated are not interchangeable, and none of those phrases is a nickel-free certificate. Confirm the cartridge is factory-sealed, single-use, and discarded after the session.

4. Disclose numbing-medicine and antiseptic reactions. FDA’s consumer update tells patients to mention allergies or sensitivities to numbing medications, because topical anesthesia is typically applied first. Cleveland Clinic lists frequent skin rashes (contact dermatitis) among conditions to discuss beforehand. The Yadav confounders make this question as important as the metal question.

5. Ask about a non-visible test spot. Gowda and colleagues recommended a trial procedure in a non-visible body area before treating exposed sites. Margulies suggested test spots in patch-test-proven nickel allergy. Neither paper specifies a 7- to 14-day waiting interval; timing belongs to the treating clinician.

6. Treat “hypoallergenic titanium” marketing as a claim to test, not a fact. Wholesaler pages that contrast nickel-containing steel with “biocompatible” titanium rarely publish release data. The published nickel case involved a titanium-coated stainless-steel roller, and gold coatings are themselves allergenic for some people.

For device identity and adverse-event context, see FDA-Cleared Powered Microneedling Devices: SkinPen vs. Exceed vs. SkinStylus and Microneedling device adverse events: what 66 FDA MAUDE reports actually show.

Reaction or normal recovery? A timing comparison

FDA’s consumer update lists bleeding, bruising, redness, tightness, itching, and peeling among expected effects that typically go away without treatment after a few days or weeks. SkinPen Precision’s 510(k) summary recorded common treatment responses of dryness, redness, burning, and itch lasting 1–3 days, with tenderness and peeling lasting up to 1–7 days in that neck-wrinkle study. Those timelines describe ordinary recovery. They do not prove that a later rash is allergy, and early redness does not rule allergy out.

Type IV metal allergy is delayed by definition. If treated skin looks like a moderate sunburn the evening of the procedure, that matches expected wound healing. If the skin seems to settle and then, days later, becomes a new itchy, spreading rash, that timing is a reason to call the clinic—not a reason to diagnose yourself from a table. Topicals remain a competing explanation until a clinician evaluates them.

Darker skin and pigment risk: what is known and what is not

Gowda and colleagues called post-inflammatory hyperpigmentation a justifiable concern after microneedling, particularly in darker skin types. Evidence across the studies they reviewed was mixed: some reported pigment change, others did not. They advised avoiding obvious sun exposure and using photoprotection. FDA’s device page separately notes that people with darker skin types face a risk of darkening or lightening after the procedure, and that some authorized devices were not studied in darker skin types.

No published study reports nickel- or gold-allergy outcomes by Fitzpatrick phototype after microneedling. The pigment discussion above is general microneedling evidence. It is not a measured PIH rate after metal-allergic flares in Fitzpatrick IV–VI skin, and it is not a duration estimate for that unstudied event. Because prolonged inflammation can precede PIH in other settings, the evidence gap itself is the clinically useful point: patients with skin of color who also have metal allergy have more reason to disclose, verify the device, and ask about a test spot, without inflating an unmeasured pigment penalty. Site coverage of pigment complications is in Post-inflammatory hyperpigmentation after aesthetic procedures.

What the evidence still cannot tell you

As of the May 2026 issue of Dermatologic Surgery and the 2025–2026 gold case reports, these limits still stand:

• Incidence is unknown. There is no prospective comparison of dermatitis or healing times in metal-allergic versus non-allergic microneedling patients. Rigali and colleagues explicitly called for that study. Case reports cannot support an incidence rate.

• Brand identity is hidden in the only multi-device screen. Devices A–E cannot be mapped onto named pens or rollers. SkinPen Precision’s separate DMG-negative tests do not place it inside or outside that sample.

• DMG is a screen, not composition analysis. It does not measure alloy grade, does not quantify weekly elution, and misses a large share of EN 1811-positive items. It also does not recreate a needle moving through living skin.

• No prescreening guideline exists. AAD, ASDS, and FDA have not issued a metal-allergy patch-test requirement before aesthetic skin puncturing. A screening question and a test spot are literature suggestions, not mandated steps.

• Coatings remain untested as allergy-prevention strategies. Titanium-coated and gold-coated needles have not been shown in head-to-head clinical studies to protect nickel-allergic patients. Gold coating introduces a second allergen for a subset of people.

Until prospective data exist, the defensible patient move is disclosure, device verification, and attention to delayed, spreading itch—not blanket avoidance and not vendor reassurance. Bring the metal history to a trained clinician and let that visit, not a product page, decide whether and how to proceed.

Sources

• U.S. Food and Drug Administration. Microneedling Devices (Aesthetic/Cosmetic Devices). Content current as of October 15, 2025.

• U.S. Food and Drug Administration. Microneedling Devices: Getting to the Point on Benefits, Risks and Safety. FDA Consumer Update, current as of October 15, 2025.

• eCFR. 21 CFR 878.4430: Microneedling device for aesthetic use. Current as of September 14, 2026 on eCFR at research access.

• U.S. Food and Drug Administration. 510(k) Summary K202243: SkinPen Precision System (Crown Aesthetics). Cleared April 2, 2021.

• Margulies S, Samia AM, Montañez-Wiscovich M, Saikaly SK. Microneedling in the nickel-allergic patient. JAAD International. 2022;9:48-49.

• Rigali S, Zeng C, Scheman A, Moraga R, Liszewski W. Nickel Secretion and the Allergenic Potential of Cosmetic Microneedles. Dermatologic Surgery. 2026;52(5):464-468 (May 2026 issue; epub 13 October 2025).

• Yadav S, Dogra S. A Cutaneous Reaction to Microneedling for Postacne Scarring Caused by Nickel Hypersensitivity. Aesthetic Surgery Journal. 2016;36(4):NP168-NP170.

• Gowda A, Healey B, Ezaldein H, Merati M. A Systematic Review Examining the Potential Adverse Effects of Microneedling. Journal of Clinical and Aesthetic Dermatology. 2021;14(1):45-54.

• Warshaw EM, et al. Epidemiology of nickel sensitivity: Retrospective cross-sectional analysis of North American Contact Dermatitis Group data 1994-2014. Journal of the American Academy of Dermatology. 2019;80(3):701-713.

• Alinaghi F, Bennike NH, Egeberg A, Thyssen JP, Johansen JD. Prevalence of contact allergy in the general population: A systematic review and meta-analysis. Contact Dermatitis. 2019;80(2):77-85.

• Zhu M, Vinturache A, Ding G. Nickel allergic contact dermatitis. CMAJ. 2022;194(33):E1136.

• Seatamanoch N, Ruxrungtham P. Gold Allergy Associated With Persistent Reactions Post Fractional Radiofrequency Microneedling Treatment. Contact Dermatitis. 2025;93(5):424-426.

• Berná-Rico E, Alonso L, Jaén P, Gómez de la Fuente E. Gold-Induced Hypersensitivity Reaction After Fractional Radiofrequency Microneedling: A Case Report. Contact Dermatitis. Published online May 25, 2026.

• Jensen MB, et al. Prevalence of contact allergy to gold in dermatitis patients from 2010 to 2024: A systematic review and meta-analysis. Contact Dermatitis. 2024. doi:10.1111/cod.14707.

• DermNet New Zealand. Contact allergy to gold. Clinical reference, September 2020.

• Thyssen JP, Skare L, Lundgren L, et al. Sensitivity and specificity of the nickel spot (dimethylglyoxime) test. Contact Dermatitis. 2010;62(5):279-288.

• Boyd AH, Hylwa SA. Nickel release from surgical instruments and operating room equipment. Dermatology Online Journal. 2018;24(4).

• Cleveland Clinic. Microneedling: What It Is, Uses, Benefits & Results. Medically reviewed; last updated May 23, 2022.

• Xdermaroller. Derma Roller Needle Material: Stainless Steel vs Titanium. Vendor marketing page used only to document the claim landscape.